deltatrials
Recruiting PHASE1 Interventional 1-arm NCT02769156

A Pilot & Feasibility Study of Intraoperative Imaging With OTL38 In Patients With Lung and Pleural Nodules

Sponsor: Abramson Cancer Center of the University of Pennsylvania

Conditions a Diagnosis of Any Resectable Lung or Pleural Nodule
Interventions Artemis and/or the Karl Storz DP camera Benadryl OTL38
Updated 5 times since 2017 Last updated: Apr 9, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates a Diagnosis of Any Resectable Lung or Pleural Nodule and is currently actively recruiting participants. Abramson Cancer Center of the University of Pennsylvania leads this study, which shows 5 recorded versions since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotRecruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotRecruiting~Sep 2018 – ~May 2019 · 8 months · monthly snapshotRecruiting~May 2019 – present · 86 months · monthly snapshotRecruiting

Change History

5 versions recorded

  1. May 2019 — Present [monthly]

    Recruiting PHASE1

  2. Sep 2018 — May 2019 [monthly]

    Recruiting PHASE1

  3. Jun 2018 — Sep 2018 [monthly]

    Recruiting PHASE1

  4. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

  5. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Abramson Cancer Center of the University of Pennsylvania
Data source: Abramson Cancer Center of the University of Pennsylvania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations